Difficulty: Medium
Average Score: 69%
Practice
All of the following statements regarding Phenylephrine are true except for
Correct answer
C
Rationale
In the context of hematological drugs, understanding the pharmacological properties of Phenylephrine is crucial for healthcare professionals. In this question, the correct answer is C: "Vasoconstriction is uncommon with topical agents, but is a concern with oral agents."
This statement is false because vasoconstriction is actually a common effect of Phenylephrine, regardless of whether it is administered orally or topically. Phenylephrine is a sympathomimetic amine that acts primarily by stimulating alpha-adrenergic receptors, leading to vasoconstriction. Therefore, this statement is inaccurate.
Now, let's analyze why the other options are incorrect:
A) "Topical agents are usually more effective and work faster." This statement is generally true because topical application allows for direct delivery to the site of action, resulting in faster onset of action compared to oral administration.
B) "Topical agents have a shorter duration." This statement is also generally true because topical formulations often have a shorter duration of action compared to oral formulations due to factors such as rapid absorption and metabolism at the application site.
D) "Oral agents always lead to rebound congestion." This statement is incorrect because while rebound congestion can occur with the prolonged use of oral decongestants like Phenylephrine, it does not always happen and is not exclusive to oral administration.
In an educational context, understanding the differences between oral and topical administration of Phenylephrine is essential for healthcare professionals to make informed decisions regarding its use in clinical practice. By knowing the pharmacokinetic and pharmacodynamic properties of Phenylephrine, healthcare providers can optimize patient outcomes and minimize potential adverse effects.
This statement is false because vasoconstriction is actually a common effect of Phenylephrine, regardless of whether it is administered orally or topically. Phenylephrine is a sympathomimetic amine that acts primarily by stimulating alpha-adrenergic receptors, leading to vasoconstriction. Therefore, this statement is inaccurate.
Now, let's analyze why the other options are incorrect:
A) "Topical agents are usually more effective and work faster." This statement is generally true because topical application allows for direct delivery to the site of action, resulting in faster onset of action compared to oral administration.
B) "Topical agents have a shorter duration." This statement is also generally true because topical formulations often have a shorter duration of action compared to oral formulations due to factors such as rapid absorption and metabolism at the application site.
D) "Oral agents always lead to rebound congestion." This statement is incorrect because while rebound congestion can occur with the prolonged use of oral decongestants like Phenylephrine, it does not always happen and is not exclusive to oral administration.
In an educational context, understanding the differences between oral and topical administration of Phenylephrine is essential for healthcare professionals to make informed decisions regarding its use in clinical practice. By knowing the pharmacokinetic and pharmacodynamic properties of Phenylephrine, healthcare providers can optimize patient outcomes and minimize potential adverse effects.